---
$id: https://graph.org.ai/products/commodity/51433909
$type: Product
source: UNSPSC
code: "51433909"
title: "Omapatrilat"
class: "51433900"
classTitle: "Antihypertensive pyridines"
family: "51430000"
familyTitle: "Antihypertensive drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Omapatrilat

**UNSPSC Code**: 51433909
**Class**: [Antihypertensive pyridines](Antihypertensive pyridines.mdx)
**Family**: [Antihypertensive drugs](../Antihypertensive drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an ace inhibitor with the molecular formula C19H24N2O4S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 36NLI90E7T, chemically known as 7h-pyrido(2,1-b)(1,3)thiazepine-7-carboxylic acid, octahydro-4-(((2s)-2-mercapto-1-oxo-3-phenylpropyl)amino)-5-oxo-, (4s,7s,10as)- but generally known as omapatrilat, which bears US NIH Compound Identifier 126046. European Medicines Agency schedules Omapatrilat in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12450MIG. The term OMAPATRILAT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 2 1999, List 40). OMAPATRILAT is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule omapatrilat under HS 29349990 and SITC 51579. As of Q4 2014, OMAPATRILAT remains the US FDA Preferred Term for this commodity. Omapatrilat bears US NLM identifiers UMLS ID C0663645 and NCI Concept Code C1782. SMILES: S1C2N(C(CCC2)C(=O)O)C(=O)C(NC(=O)C(S)Cc2ccccc2)CC1.

